Plas-Free

📍 Nazareth, Israel🗓 Founded 2017👥 20 employees💰 Last funded May 2024
Plas-Free is a clinical-stage medical device company developing an advanced filtration technology for blood purification with the aim to save lives and reduce healthcare costs. Plas-Free’s upcoming products provide a simple yet revolutionary approach to advance critical care that address clear unmet needs: 1. ClearPlasma for use during massive internal bleeding modifies human plasma to enhance coagulation and hemostasis, effectively reducing bleeding by 55% in clinical studies. 2. AAPC-300 for use in HyperAmmonia in liver malfunctions, removes ammonia from the blood stream, effectively extracting > 80% of the ammonia in clinical studies. Plas-Free operates as part of a portfolio company of NGT3VC Healthcare venture capital fund. The company is active both in Israel and the US (PA). To learn more, visit www.plas-free.com or follow us on Linkedin.
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2017
Founded
Investor geography1 country
France
3
Frequently asked questions
Who invested in Plas-Free?
Plas-Free has 3 investors on record on gritt.io and 3 late-stage investors.
When did Plas-Free last raise funding?
The most recent investment in Plas-Free recorded on gritt.io was in May 2024.
When was Plas-Free founded?
Plas-Free was founded in 2017.
What industry is Plas-Free in?
Plas-Free operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Plas-Free based?
Plas-Free is headquartered in Nazareth, Israel.